Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine.
Nabin K ShresthaPatrick C BurkeAmy S NowackiJames F SimonAmanda HagenSteven M GordonPublished in: Open forum infectious diseases (2023)
The bivalent COVID-19 vaccine given to working-aged adults afforded modest protection overall against COVID-19 while the BA.4/5 lineages were the dominant circulating strains, afforded less protection when the BQ lineages were dominant, and effectiveness was not demonstrated when the XBB lineages were dominant.